The FDA granted Breakthrough Therapy designation to IDE196 for the neoadjuvant treatment of primary uveal melanoma when ...

Uveal melanoma, or ocular melanoma, is a cancer that happens inside your eyeball. It’s rare. Just 7 out of every 1 million people get it each year. But it’s also the most common eye cancer for ...

The rare ocular, acral and mucosal melanoma subtypes have no known environmental risk factors, making early detection and ...

As many as half of people diagnosed with uveal melanoma (ocular melanoma) go on to have what’s called metastatic disease. Most often, the cancer metastasizes (spreads) beyond the eye to the ...

Onctura has dosed the first subject in the Phase II OCULE-01 trial of oral roginolisib in individuals with metastatic uveal ...

The summer of 2023 saw the approval of a new treatment option for certain patients with uveal melanoma, a form of cancer that begins in the eye and remains a challenge to treat. Richard Staines ...

Investigators studied the relationship between Fitzpatrick skin type and the characteristics and outcomes associated with 2 types of ocular melanoma.

Gemma Small now she needs £200k for treatment to give her the vital chance to make precious memories with her son while she ...

Patient-derived organoids can be established from uveal melanoma tumors. Credit: Investigative Ophthalmology & Visual Science (2024). DOI: 10.1167/iovs.65.13.60 ...

A phase 3 trial plans to further assess neoadjuvant darovasertib for the potential treatment of patients with primary uveal melanoma.

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of ...